Global Gabapentin Enacarbil Market Growth 2020-2025
According to this study, over the next five years the Gabapentin Enacarbil market will register a XX%% CAGR in terms of revenue, the global market size will reach $ XX million by 2025, from $ XX million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Gabapentin Enacarbil business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Gabapentin Enacarbil market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Gabapentin Enacarbil, covering the supply chain analysis, impact assessment to the Gabapentin Enacarbil market size growth rate in several scenarios, and the measures to be undertaken by Gabapentin Enacarbil companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Capsule
Tablet
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Post-Herpetic Neuralgia (PHN)
Restless Legs Syndrome (RLS)
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Arbor Pharma
Apotex
Astellas
Glenmark Pharma
Pfizer
GlaxoSmithKline
Mylan
Depomed
Novartis
Teva
Alkem
Jiangsu Hengrui
Jiangsu Enhua
Sun Pharmaceutical
Amneal
Intas
Marksans Pharma
Aurobindo Pharma
Sailike Pharma
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Gabapentin Enacarbil consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Gabapentin Enacarbil market by identifying its various subsegments.
Focuses on the key global Gabapentin Enacarbil manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Gabapentin Enacarbil with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Gabapentin Enacarbil submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gabapentin Enacarbil Consumption 2015-2025
2.1.2 Gabapentin Enacarbil Consumption CAGR by Region
2.2 Gabapentin Enacarbil Segment by Type
2.2.1 Capsule
2.2.2 Tablet
2.3 Gabapentin Enacarbil Consumption by Type
2.3.1 Global Gabapentin Enacarbil Consumption Market Share by Type (2015-2020)
2.3.2 Global Gabapentin Enacarbil Revenue and Market Share by Type (2015-2020)
2.3.3 Global Gabapentin Enacarbil Sale Price by Type (2015-2020)
2.4 Gabapentin Enacarbil Segment by Application
2.4.1 Post-Herpetic Neuralgia (PHN)
2.4.2 Restless Legs Syndrome (RLS)
2.4.3 Others
2.5 Gabapentin Enacarbil Consumption by Application
2.5.1 Global Gabapentin Enacarbil Consumption Market Share by Type (2015-2020)
2.5.2 Global Gabapentin Enacarbil Value and Market Share by Type (2015-2020)
2.5.3 Global Gabapentin Enacarbil Sale Price by Type (2015-2020)
3 Global Gabapentin Enacarbil by Company
3.1 Global Gabapentin Enacarbil Sales Market Share by Company
3.1.1 Global Gabapentin Enacarbil Sales by Company (2018-2020)
3.1.2 Global Gabapentin Enacarbil Sales Market Share by Company (2018-2020)
3.2 Global Gabapentin Enacarbil Revenue Market Share by Company
3.2.1 Global Gabapentin Enacarbil Revenue by Company (2018-2020)
3.2.2 Global Gabapentin Enacarbil Revenue Market Share by Company (2018-2020)
3.3 Global Gabapentin Enacarbil Sale Price by Company
3.4 Global Gabapentin Enacarbil Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Gabapentin Enacarbil Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Gabapentin Enacarbil Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Gabapentin Enacarbil by Regions
4.1 Gabapentin Enacarbil by Regions
4.2 Americas Gabapentin Enacarbil Consumption Growth
4.3 APAC Gabapentin Enacarbil Consumption Growth
4.4 Europe Gabapentin Enacarbil Consumption Growth
4.5 Middle East & Africa Gabapentin Enacarbil Consumption Growth
5 Americas
5.1 Americas Gabapentin Enacarbil Consumption by Countries
5.1.1 Americas Gabapentin Enacarbil Consumption by Countries (2015-2020)
5.1.2 Americas Gabapentin Enacarbil Value by Countries (2015-2020)
5.2 Americas Gabapentin Enacarbil Consumption by Type
5.3 Americas Gabapentin Enacarbil Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Gabapentin Enacarbil Consumption by Regions
6.1.1 APAC Gabapentin Enacarbil Consumption by Regions (2015-2020)
6.1.2 APAC Gabapentin Enacarbil Value by Regions (2015-2020)
6.2 APAC Gabapentin Enacarbil Consumption by Type
6.3 APAC Gabapentin Enacarbil Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Gabapentin Enacarbil by Countries
7.1.1 Europe Gabapentin Enacarbil Consumption by Countries (2015-2020)
7.1.2 Europe Gabapentin Enacarbil Value by Countries (2015-2020)
7.2 Europe Gabapentin Enacarbil Consumption by Type
7.3 Europe Gabapentin Enacarbil Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Gabapentin Enacarbil by Countries
8.1.1 Middle East & Africa Gabapentin Enacarbil Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Gabapentin Enacarbil Value by Countries (2015-2020)
8.2 Middle East & Africa Gabapentin Enacarbil Consumption by Type
8.3 Middle East & Africa Gabapentin Enacarbil Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Gabapentin Enacarbil Distributors
10.3 Gabapentin Enacarbil Customer
11 Global Gabapentin Enacarbil Market Forecast
11.1 Global Gabapentin Enacarbil Consumption Forecast (2021-2025)
11.2 Global Gabapentin Enacarbil Forecast by Regions
11.2.1 Global Gabapentin Enacarbil Forecast by Regions (2021-2025)
11.2.2 Global Gabapentin Enacarbil Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Gabapentin Enacarbil Forecast by Type
11.8 Global Gabapentin Enacarbil Forecast by Application
12 Key Players Analysis
12.1 Arbor Pharma
12.1.1 Company Information
12.1.2 Gabapentin Enacarbil Product Offered
12.1.3 Arbor Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Arbor Pharma Latest Developments
12.2 Apotex
12.2.1 Company Information
12.2.2 Gabapentin Enacarbil Product Offered
12.2.3 Apotex Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Apotex Latest Developments
12.3 Astellas
12.3.1 Company Information
12.3.2 Gabapentin Enacarbil Product Offered
12.3.3 Astellas Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Astellas Latest Developments
12.4 Glenmark Pharma
12.4.1 Company Information
12.4.2 Gabapentin Enacarbil Product Offered
12.4.3 Glenmark Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Glenmark Pharma Latest Developments
12.5 Pfizer
12.5.1 Company Information
12.5.2 Gabapentin Enacarbil Product Offered
12.5.3 Pfizer Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Pfizer Latest Developments
12.6 GlaxoSmithKline
12.6.1 Company Information
12.6.2 Gabapentin Enacarbil Product Offered
12.6.3 GlaxoSmithKline Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 GlaxoSmithKline Latest Developments
12.7 Mylan
12.7.1 Company Information
12.7.2 Gabapentin Enacarbil Product Offered
12.7.3 Mylan Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Mylan Latest Developments
12.8 Depomed
12.8.1 Company Information
12.8.2 Gabapentin Enacarbil Product Offered
12.8.3 Depomed Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Depomed Latest Developments
12.9 Novartis
12.9.1 Company Information
12.9.2 Gabapentin Enacarbil Product Offered
12.9.3 Novartis Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Novartis Latest Developments
12.10 Teva
12.10.1 Company Information
12.10.2 Gabapentin Enacarbil Product Offered
12.10.3 Teva Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Teva Latest Developments
12.11 Alkem
12.11.1 Company Information
12.11.2 Gabapentin Enacarbil Product Offered
12.11.3 Alkem Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Alkem Latest Developments
12.12 Jiangsu Hengrui
12.12.1 Company Information
12.12.2 Gabapentin Enacarbil Product Offered
12.12.3 Jiangsu Hengrui Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Jiangsu Hengrui Latest Developments
12.13 Jiangsu Enhua
12.13.1 Company Information
12.13.2 Gabapentin Enacarbil Product Offered
12.13.3 Jiangsu Enhua Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Jiangsu Enhua Latest Developments
12.14 Sun Pharmaceutical
12.14.1 Company Information
12.14.2 Gabapentin Enacarbil Product Offered
12.14.3 Sun Pharmaceutical Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Sun Pharmaceutical Latest Developments
12.15 Amneal
12.15.1 Company Information
12.15.2 Gabapentin Enacarbil Product Offered
12.15.3 Amneal Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Amneal Latest Developments
12.16 Intas
12.16.1 Company Information
12.16.2 Gabapentin Enacarbil Product Offered
12.16.3 Intas Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Intas Latest Developments
12.17 Marksans Pharma
12.17.1 Company Information
12.17.2 Gabapentin Enacarbil Product Offered
12.17.3 Marksans Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Marksans Pharma Latest Developments
12.18 Aurobindo Pharma
12.18.1 Company Information
12.18.2 Gabapentin Enacarbil Product Offered
12.18.3 Aurobindo Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Aurobindo Pharma Latest Developments
12.19 Sailike Pharma
12.19.1 Company Information
12.19.2 Gabapentin Enacarbil Product Offered
12.19.3 Sailike Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Sailike Pharma Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Gabapentin Enacarbil Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Capsule
Table 5. Major Players of Tablet
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Gabapentin Enacarbil Consumption Market Share by Type (2015-2020)
Table 8. Global Gabapentin Enacarbil Revenue by Type (2015-2020) ($ million)
Table 9. Global Gabapentin Enacarbil Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Gabapentin Enacarbil Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Gabapentin Enacarbil Consumption Market Share by Application (2015-2020)
Table 13. Global Gabapentin Enacarbil Value by Application (2015-2020)
Table 14. Global Gabapentin Enacarbil Value Market Share by Application (2015-2020)
Table 15. Global Gabapentin Enacarbil Sale Price by Application (2015-2020)
Table 16. Global Gabapentin Enacarbil Sales by Company (2017-2019) (K Units)
Table 17. Global Gabapentin Enacarbil Sales Market Share by Company (2017-2019)
Table 18. Global Gabapentin Enacarbil Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Gabapentin Enacarbil Revenue Market Share by Company (2017-2019)
Table 20. Global Gabapentin Enacarbil Sale Price by Company (2017-2019)
Table 21. Global Gabapentin Enacarbil Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Gabapentin Enacarbil Products Offered
Table 23. Gabapentin Enacarbil Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Gabapentin Enacarbil Consumption by Regions 2015-2020 (K Units)
Table 25. Global Gabapentin Enacarbil Consumption Market Share by Regions 2015-2020
Table 26. Global Gabapentin Enacarbil Value by Regions 2015-2020 ($ Millions)
Table 27. Global Gabapentin Enacarbil Value Market Share by Regions 2015-2020
Table 28. Americas Gabapentin Enacarbil Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Gabapentin Enacarbil Consumption Market Share by Countries (2015-2020)
Table 30. Americas Gabapentin Enacarbil Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Gabapentin Enacarbil Value Market Share by Countries (2015-2020)
Table 32. Americas Gabapentin Enacarbil Consumption by Type (2015-2020) (K Units)
Table 33. Americas Gabapentin Enacarbil Consumption Market Share by Type (2015-2020)
Table 34. Americas Gabapentin Enacarbil Consumption by Application (2015-2020) (K Units)
Table 35. Americas Gabapentin Enacarbil Consumption Market Share by Application (2015-2020)
Table 36. APAC Gabapentin Enacarbil Consumption by Countries (2015-2020) (K Units)
Table 37. APAC Gabapentin Enacarbil Consumption Market Share by Countries (2015-2020)
Table 38. APAC Gabapentin Enacarbil Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Gabapentin Enacarbil Value Market Share by Regions (2015-2020)
Table 40. APAC Gabapentin Enacarbil Consumption by Type (2015-2020) (K Units)
Table 41. APAC Gabapentin Enacarbil Consumption Market Share by Type (2015-2020)
Table 42. APAC Gabapentin Enacarbil Consumption by Application (2015-2020) (K Units)
Table 43. APAC Gabapentin Enacarbil Consumption Market Share by Application (2015-2020)
Table 44. Europe Gabapentin Enacarbil Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Gabapentin Enacarbil Consumption Market Share by Countries (2015-2020)
Table 46. Europe Gabapentin Enacarbil Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Gabapentin Enacarbil Value Market Share by Countries (2015-2020)
Table 48. Europe Gabapentin Enacarbil Consumption by Type (2015-2020) (K Units)
Table 49. Europe Gabapentin Enacarbil Consumption Market Share by Type (2015-2020)
Table 50. Europe Gabapentin Enacarbil Consumption by Application (2015-2020) (K Units)
Table 51. Europe Gabapentin Enacarbil Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Gabapentin Enacarbil Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Gabapentin Enacarbil Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Gabapentin Enacarbil Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Gabapentin Enacarbil Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Gabapentin Enacarbil Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Gabapentin Enacarbil Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Gabapentin Enacarbil Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Gabapentin Enacarbil Consumption Market Share by Application (2015-2020)
Table 60. Gabapentin Enacarbil Distributors List
Table 61. Gabapentin Enacarbil Customer List
Table 62. Global Gabapentin Enacarbil Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Gabapentin Enacarbil Consumption Market Forecast by Regions
Table 64. Global Gabapentin Enacarbil Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Gabapentin Enacarbil Value Market Share Forecast by Regions
Table 66. Global Gabapentin Enacarbil Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Gabapentin Enacarbil Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Gabapentin Enacarbil Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Gabapentin Enacarbil Value Market Share Forecast by Type (2021-2025)
Table 70. Global Gabapentin Enacarbil Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Gabapentin Enacarbil Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Gabapentin Enacarbil Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Gabapentin Enacarbil Value Market Share Forecast by Application (2021-2025)
Table 74. Arbor Pharma Product Offered
Table 75. Arbor Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 76. Arbor Pharma Main Business
Table 77. Arbor Pharma Latest Developments
Table 78. Arbor Pharma Basic Information, Company Total Revenue (in $ million), Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 79. Apotex Product Offered
Table 80. Apotex Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 81. Apotex Main Business
Table 82. Apotex Latest Developments
Table 83. Apotex Basic Information, Company Total Revenue (in $ million), Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 84. Astellas Product Offered
Table 85. Astellas Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 86. Astellas Main Business
Table 87. Astellas Latest Developments
Table 88. Astellas Basic Information, Company Total Revenue (in $ million), Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 89. Glenmark Pharma Product Offered
Table 90. Glenmark Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 91. Glenmark Pharma Main Business
Table 92. Glenmark Pharma Latest Developments
Table 93. Glenmark Pharma Basic Information, Company Total Revenue (in $ million), Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Product Offered
Table 95. Pfizer Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. Pfizer Basic Information, Company Total Revenue (in $ million), Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 99. GlaxoSmithKline Product Offered
Table 100. GlaxoSmithKline Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 101. GlaxoSmithKline Main Business
Table 102. GlaxoSmithKline Latest Developments
Table 103. GlaxoSmithKline Basic Information, Company Total Revenue (in $ million), Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 104. Mylan Product Offered
Table 105. Mylan Basic Information, Company Total Revenue (in $ million), Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 106. Mylan Main Business
Table 107. Mylan Latest Developments
Table 108. Mylan Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 109. Depomed Product Offered
Table 110. Depomed Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. Depomed Main Business
Table 112. Depomed Latest Developments
Table 113. Depomed Basic Information, Company Total Revenue (in $ million), Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 114. Novartis Product Offered
Table 115. Novartis Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 116. Novartis Main Business
Table 117. Novartis Latest Developments
Table 118. Novartis Basic Information, Company Total Revenue (in $ million), Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 119. Teva Product Offered
Table 120. Teva Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 121. Teva Main Business
Table 122. Teva Latest Developments
Table 123. Teva Basic Information, Company Total Revenue (in $ million), Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 124. Alkem Product Offered
Table 125. Alkem Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 126. Alkem Main Business
Table 127. Alkem Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Alkem Latest Developments
Table 129. Jiangsu Hengrui Product Offered
Table 130. Jiangsu Hengrui Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 131. Jiangsu Hengrui Main Business
Table 132. Jiangsu Hengrui Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Jiangsu Hengrui Latest Developments
Table 134. Jiangsu Enhua Product Offered
Table 135. Jiangsu Enhua Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 136. Jiangsu Enhua Main Business
Table 137. Jiangsu Enhua Latest Developments
Table 138. Jiangsu Enhua Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. Sun Pharmaceutical Product Offered
Table 140. Sun Pharmaceutical Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 141. Sun Pharmaceutical Main Business
Table 142. Sun Pharmaceutical Latest Developments
Table 143. Sun Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 144. Amneal Product Offered
Table 145. Amneal Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 146. Amneal Main Business
Table 147. Amneal Latest Developments
Table 148. Amneal Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 149. Intas Product Offered
Table 150. Intas Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 151. Intas Main Business
Table 152. Intas Latest Developments
Table 153. Intas Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 154. Marksans Pharma Product Offered
Table 155. Marksans Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 156. Marksans Pharma Main Business
Table 157. Marksans Pharma Latest Developments
Table 158. Marksans Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 159. Aurobindo Pharma Product Offered
Table 160. Aurobindo Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 161. Aurobindo Pharma Main Business
Table 162. Aurobindo Pharma Latest Developments
Table 163. Aurobindo Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 164. Sailike Pharma Product Offered
Table 165. Sailike Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 166. Sailike Pharma Main Business
Table 167. Sailike Pharma Latest Developments
Table 168. Sailike Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Gabapentin Enacarbil
Figure 2. Gabapentin Enacarbil Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Gabapentin Enacarbil Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Gabapentin Enacarbil Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Capsule
Figure 7. Product Picture of Tablet
Figure 8. Global Gabapentin Enacarbil Consumption Market Share by Type (2015-2020)
Figure 9. Global Gabapentin Enacarbil Value Market Share by Type (2015-2020)
Figure 10. Gabapentin Enacarbil Consumed in Post-Herpetic Neuralgia (PHN)
Figure 11. Global Gabapentin Enacarbil Market: Post-Herpetic Neuralgia (PHN) (2015-2020) (K Units)
Figure 12. Global Gabapentin Enacarbil Market: Post-Herpetic Neuralgia (PHN) (2015-2020) ($ Millions)
Figure 13. Gabapentin Enacarbil Consumed in Restless Legs Syndrome (RLS)
Figure 14. Global Gabapentin Enacarbil Market: Restless Legs Syndrome (RLS) (2015-2020) (K Units)
Figure 15. Global Gabapentin Enacarbil Market: Restless Legs Syndrome (RLS) (2015-2020) ($ Millions)
Figure 16. Gabapentin Enacarbil Consumed in Others
Figure 17. Global Gabapentin Enacarbil Market: Others (2015-2020) (K Units)
Figure 18. Global Gabapentin Enacarbil Market: Others (2015-2020) ($ Millions)
Figure 19. Global Gabapentin Enacarbil Consumption Market Share by Application (2015-2020)
Figure 20. Global Gabapentin Enacarbil Value Market Share by Application (2015-2020)
Figure 21. Global Gabapentin Enacarbil Sales Market Share by Company in 2017
Figure 22. Global Gabapentin Enacarbil Sales Market Share by Company in 2019
Figure 23. Global Gabapentin Enacarbil Revenue Market Share by Company in 2017
Figure 24. Global Gabapentin Enacarbil Revenue Market Share by Company in 2019
Figure 25. Global Gabapentin Enacarbil Sale Price by Company in 2019
Figure 26. Global Gabapentin Enacarbil Consumption Market Share by Regions 2015-2020
Figure 27. Global Gabapentin Enacarbil Value Market Share by Regions 2015-2020
Figure 28. Americas Gabapentin Enacarbil Consumption 2015-2020 (K Units)
Figure 29. Americas Gabapentin Enacarbil Value 2015-2020 ($ Millions)
Figure 30. APAC Gabapentin Enacarbil Consumption 2015-2020 (K Units)
Figure 31. APAC Gabapentin Enacarbil Value 2015-2020 ($ Millions)
Figure 32. Europe Gabapentin Enacarbil Consumption 2015-2020 (K Units)
Figure 33. Europe Gabapentin Enacarbil Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Gabapentin Enacarbil Consumption 2015-2020 (K Units)
Figure 35. Middle East & Africa Gabapentin Enacarbil Value 2015-2020 ($ Millions)
Figure 36. Americas Gabapentin Enacarbil Consumption Market Share by Countries in 2019
Figure 37. Americas Gabapentin Enacarbil Value Market Share by Countries in 2019
Figure 38. Americas Gabapentin Enacarbil Consumption Market Share by Type in 2019
Figure 39. Americas Gabapentin Enacarbil Consumption Market Share by Application in 2019
Figure 40. United States Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)
Figure 41. United States Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)
Figure 43. Canada Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)
Figure 45. Mexico Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Gabapentin Enacarbil Consumption Market Share by Countries in 2019
Figure 47. APAC Gabapentin Enacarbil Value Market Share by Regions in 2019
Figure 48. APAC Gabapentin Enacarbil Consumption Market Share by Type in 2019
Figure 49. APAC Gabapentin Enacarbil Consumption Market Share by Application in 2019
Figure 50. China Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)
Figure 51. China Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)
Figure 53. Japan Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)
Figure 55. Korea Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)
Figure 57. Southeast Asia Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)
Figure 58. India Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)
Figure 59. India Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)
Figure 61. Australia Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Gabapentin Enacarbil Consumption Market Share by Countries in 2019
Figure 63. Europe Gabapentin Enacarbil Value Market Share by Countries in 2019
Figure 64. Europe Gabapentin Enacarbil Consumption Market Share by Type in 2019
Figure 65. Europe Gabapentin Enacarbil Consumption Market Share by Application in 2019
Figure 66. Germany Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)
Figure 67. Germany Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)
Figure 68. France Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)
Figure 69. France Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)
Figure 70. UK Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)
Figure 71. UK Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)
Figure 73. Italy Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)
Figure 75. Russia Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Gabapentin Enacarbil Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Gabapentin Enacarbil Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Gabapentin Enacarbil Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Gabapentin Enacarbil Consumption Market Share by Application in 2019
Figure 80. Egypt Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)
Figure 81. Egypt Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)
Figure 83. South Africa Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)
Figure 85. Israel Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)
Figure 87. Turkey Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)
Figure 89. GCC Countries Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)
Figure 90. Global Gabapentin Enacarbil Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 91. Global Gabapentin Enacarbil Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 93. Americas Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 94. APAC Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 95. APAC Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 96. Europe Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 97. Europe Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 99. Middle East & Africa Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 100. United States Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 101. United States Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 102. Canada Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 103. Canada Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 104. Mexico Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 105. Mexico Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 106. Brazil Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 107. Brazil Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 108. China Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 109. China Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 110. Japan Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 111. Japan Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 112. Korea Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 113. Korea Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 115. Southeast Asia Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 116. India Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 117. India Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 118. Australia Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 119. Australia Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 120. Germany Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 121. Germany Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 122. France Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 123. France Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 124. UK Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 125. UK Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 126. Italy Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 127. Italy Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 128. Russia Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 129. Russia Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 130. Spain Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 131. Spain Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 132. Egypt Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 133. Egypt Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 134. South Africa Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 135. South Africa Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 136. Israel Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 137. Israel Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 138. Turkey Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 139. Turkey Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Gabapentin Enacarbil Consumption 2021-2025 (K Units)
Figure 141. GCC Countries Gabapentin Enacarbil Value 2021-2025 ($ Millions)
Figure 142. Arbor Pharma Gabapentin Enacarbil Market Share (2018-2020)
Figure 143. Apotex Gabapentin Enacarbil Market Share (2018-2020)
Figure 144. Astellas Gabapentin Enacarbil Market Share (2018-2020)
Figure 145. Glenmark Pharma Gabapentin Enacarbil Market Share (2018-2020)
Figure 146. Pfizer Gabapentin Enacarbil Market Share (2018-2020)
Figure 147. GlaxoSmithKline Gabapentin Enacarbil Market Share (2018-2020)
Figure 148. Mylan Gabapentin Enacarbil Market Share (2018-2020)
Figure 149. Depomed Gabapentin Enacarbil Market Share (2018-2020)
Figure 150. Novartis Gabapentin Enacarbil Market Share (2018-2020)
Figure 151. Teva Gabapentin Enacarbil Market Share (2018-2020)
Figure 152. Alkem Gabapentin Enacarbil Market Share (2018-2020)
Figure 153. Jiangsu Hengrui Gabapentin Enacarbil Market Share (2018-2020)
Figure 154. Jiangsu Enhua Gabapentin Enacarbil Market Share (2018-2020)
Figure 155. Sun Pharmaceutical Gabapentin Enacarbil Market Share (2018-2020)
Figure 156. Amneal Gabapentin Enacarbil Market Share (2018-2020)
Figure 157. Intas Gabapentin Enacarbil Market Share (2018-2020)
Figure 158. Marksans Pharma Gabapentin Enacarbil Market Share (2018-2020)
Figure 159. Aurobindo Pharma Gabapentin Enacarbil Market Share (2018-2020)
Figure 160. Sailike Pharma Gabapentin Enacarbil Market Share (2018-2020)
